Drug Approval | July 24, 2024
Shilpa Biologicals receives registration approval for Adalimumab from Morocco, MoH
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
The innovative ‘Street Safe’ Rapid Testing Kit should be provided to all vendors attending the Food Safety and Certification (FoSTaC) trainings to ensure that safe food is used by the street food vendors across the country
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
The pooled prevalence of GERD in the Indian population is 15.6 %
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
Dyslipidemia is a critical risk factor for cardiovascular diseases
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Signs MoUs with Shri Krishna Ayush University and Dabur India
Subscribe To Our Newsletter & Stay Updated
